Oracle Corporation $ORCL Shares Purchased by Global X Japan Co. Ltd.

Key Points

• Global X Japan Co. Ltd. increased its stake in Oracle Corporation by 8.0% during the second quarter, holding 12,178 shares valued at approximately $2.66 million.
• Insider Michael D. Sicilia sold 16,323 shares worth over $5.11 million, resulting in a 12.91% decrease in his ownership of the company.
• Oracle recently announced a quarterly dividend of $0.50 per share, yielding 0.6%, with an ex-dividend date set for October 9th.

Global X Japan Co. Ltd. boosted its position in Oracle Corporation (NYSE:ORCL - Free Report) by 8.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,178 shares of the enterprise software provider's stock after acquiring an additional 898 shares during the quarter. Global X Japan Co. Ltd.'s holdings in Oracle were worth $2,662,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Redmont Wealth Advisors LLC acquired a new stake in shares of Oracle during the 1st quarter worth about $27,000. Inlight Wealth Management LLC acquired a new stake in shares of Oracle during the 1st quarter worth about $28,000. Iron Horse Wealth Management LLC increased its position in Oracle by 284.9% during the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock worth $29,000 after buying an additional 151 shares during the period. Sunbeam Capital Management LLC acquired a new position in Oracle during the fourth quarter worth approximately $30,000. Finally, Fourth Dimension Wealth LLC acquired a new position in Oracle during the fourth quarter worth approximately $36,000. Institutional investors and hedge funds own 42.44% of the company's stock.

Insider Transactions at Oracle

In related news, insider Michael D. Sicilia sold 16,323 shares of the firm's stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $313.60, for a total value of $5,118,892.80. Following the sale, the insider directly owned 110,094 shares in the company, valued at $34,525,478.40. This trade represents a 12.91% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rona Alison Fairhead purchased 480 shares of the stock in a transaction dated Monday, July 7th. The shares were purchased at an average price of $233.87 per share, for a total transaction of $112,257.60. Following the completion of the transaction, the director owned 22,110 shares in the company, valued at $5,170,865.70. This trade represents a 2.22% increase in their position. The disclosure for this purchase can be found here. Insiders sold 78,247 shares of company stock worth $22,090,505 over the last quarter. Insiders own 42.20% of the company's stock.

Analyst Ratings Changes

Several research firms have commented on ORCL. Royal Bank Of Canada lifted their price target on Oracle from $145.00 to $195.00 and gave the stock a "sector perform" rating in a research report on Thursday, June 12th. Guggenheim lifted their target price on Oracle from $250.00 to $375.00 and gave the company a "buy" rating in a research note on Wednesday, September 10th. Cowen reiterated a "buy" rating and issued a $375.00 target price on shares of Oracle in a research note on Wednesday, September 10th. Loop Capital set a $135.00 target price on Oracle in a research note on Tuesday, June 10th. Finally, Piper Sandler lifted their target price on Oracle from $270.00 to $330.00 and gave the company an "overweight" rating in a research note on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating, twenty-four have issued a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $303.44.

Oracle Trading Up 4.2%

NYSE:ORCL opened at $309.18 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The business's 50 day moving average is $251.63 and its two-hundred day moving average is $195.16. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72. The company has a market cap of $878.60 billion, a PE ratio of 71.57, a P/E/G ratio of 3.21 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). The firm had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company's quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, analysts predict that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.6%. The ex-dividend date is Thursday, October 9th. Oracle's dividend payout ratio (DPR) is currently 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.